等待開盤 10-10 09:30:00 美东时间
+0.550
+1.58%
今日重点评级关注:HC Wainwright & Co.:维持Inventiva"买入"评级,目标价从20美元升至24美元;摩根大通:维持BioMarin Pharmaceutical"超配"评级,目标价从116美元升至119美元
今天 11:36
今日重点评级关注:富国银行:维持Kyverna Therapeutics"超配"评级,目标价从24美元升至27美元;Chardan Capital:维持Oculis Holding"买入"评级,目标价从33美元升至51美元
10-09 10:51
UBS analyst Peter Grom maintains BellRing Brands (NYSE:BRBR) with a Neutral and lowers the price target from $40 to $39.
10-09 00:08
BellRing Brands, Inc. (NYSE:BRBR) today announced its Board of Directors approved a $400 million share repurchase authorization over the next two years with share repurchases under the new authorization beginning on
09-02 20:03
<p>BellRing Brands, Inc. announced a $400 million share repurchase authorization over the next two years, with repurchases beginning on September 2, 2025. As of August 29, 2025, the company had repurchased 3.1 million shares for $123.4 million under its previous $300 million authorization, which was canceled. Repurchases may occur in various methods, but their timing and amount depend on factors like liquidity, market conditions, and legal requir...
09-02 12:00
今日重点评级关注:Craig-Hallum:维持Applied Digital"买入"评级,目标价从12美元升至23美元;HC Wainwright & Co.:维持Bitdeer Technologies"买入"评级,目标价从18美元升至19美元
08-19 09:56
Mizuho analyst John Baumgartner maintains BellRing Brands (NYSE:BRBR) with a Outperform and lowers the price target from $75 to $45.
08-19 02:09
BellRing Brands ($BRBR) saw a wave of insider activity in mid-August, highlight...
08-17 17:30
本周涨超137%!次新股MENS上市已累涨超500%;以太坊概念股BMNR周涨超62%,特朗普新政允许401K账户投资加密货币等其他另类投资>>
08-09 10:07
今日重点评级关注:韦德布什:维持Gossamer Bio"跑赢大市"评级,目标价从4美元升至5美元;HC Wainwright & Co.:维持EyePoint Pharmaceuticals"买入"评级,目标价从22美元升至23美元
08-07 09:46